“Lipella Pharmaceuticals Receives FDA Approval for Expanded Access Program of LP-310 in Oral Lichen Planus”

Pittsburgh Welcomes Lipella Pharmaceuticals Inc. February 6, 2025 – PRISM MediaWire Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) announced today Exciting news hit the biotechnology industry today as Lipella Pharmaceuticals Inc. announced its arrival in Pittsburgh. With a focus on developing innovative therapies for unmet medical needs, Lipella is set to make a significant impact in the…

Read More

“Breaking Records: Linde Surpasses Q4 Earnings Expectations for 2025”

Linde Beats Market Expectations with Strong Fourth Quarter Earnings The Rise of Linde: A Success Story Linde, the world’s largest industrial gases company, has once again proven its dominance in the market with its impressive fourth quarter earnings. The company reported earnings that surpassed market expectations, showcasing its strong performance and solid growth trajectory. With…

Read More

“Calling All Enphase Energy Inc. Investors: Don’t Miss Your Chance to Take Action and Lead the Charge in a Class Action Lawsuit!”

Robbins Geller Rudman & Dowd LLP Announces Deadline in Enphase Energy, Inc. Securities Class Action Lawsuit SAN DIEGO, Feb. 6, 2025 /PRNewswire/ — Introduction Robbins Geller Rudman & Dowd LLP has notified purchasers or acquirers of Enphase Energy, Inc. (NASDAQ: ENPH) common stock that they have until Tuesday, February 11, 2025, to seek appointment as…

Read More